NIH Revises Reimbursement Rules for High-Volume Microarray Studies

Citing the "relatively high" price of chips, particularly for use in genome-wide association studies, the NIH last month updated its reimbursement policy for projects with microarray costs of more than $50,000 per year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.